KREBSBIO — Krebs Biochemicals And Industries Share Price
0.000.00%
Last trade - 00:00- IN₹1.70bn
- IN₹3.63bn
- IN₹504.22m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.44 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -23.96% | ||
| Return on Equity | n/a | ||
| Operating Margin | -39.7% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 334.12 | 537 | 597.03 | 521.34 | 504.21 | n/a | n/a | 1.09% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Krebs Biochemicals & Industries Ltd is an India-based company, which is engaged in the business of manufacture of active pharmaceutical ingredients. The Company manufactures bulk active pharmaceutical ingredients, pharmaceutical intermediates, fine chemicals, nutraceuticals utilizing two revenue streams: contract manufacturing for large pharmaceutical and multinational companies, and development of its products for sale in global markets. Its products include Androstenedione, Lovastatin, and Simvastatin. The Company’s pilot or research and development stages products are Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan, and Phenylephrine. The Company has two manufacturing facilities one at Regadichelaka, Nellore District and another one at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.
Directors
- R. Ravi NEC
- Pabitra Bhattacharya MDR (28)
- Taruni Banda SEC
- Avinash Ravi NED (41)
- Jitendra Shah NED
- Satish Khivsara IND
- Raj Verma IND
- G. Prasad NID (58)
- R. Satyanarayana NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 2nd, 1991
- Public Since
- March 2nd, 1994
- No. of Shareholders
- 8,911
- No. of Employees
- 191
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 21,560,600
- Address
- Inwinex Towers, Plot No. 130, 4th Floor, HYDERABAD, 500034
- Web
- http://krebsbiochem.com
- Phone
- +91 4066808040
- Auditors
- M/s. Bhavani & Co
Upcoming Events for KREBSBIO
Q1 2026 Krebs Biochemicals and Industries Ltd Earnings Release
Krebs Biochemicals and Industries Ltd Annual Shareholders Meeting
Similar to KREBSBIO
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Krebs Biochemicals And Industries share price?
As of Today at 21:38 UTC, shares in Krebs Biochemicals And Industries are trading at IN₹78.41. This share price information is delayed by 15 minutes.
How has the Krebs Biochemicals And Industries share price performed this year?
Shares in Krebs Biochemicals And Industries last closed at IN₹78.41 and the price had moved by +9.59% over the past 365 days. In terms of relative price strength the Krebs Biochemicals And Industries share price has outperformed the S&P BSE 100 Index by +3.23% over the past year.
What are the analyst and broker recommendations for Krebs Biochemicals And Industries?
There is no consensus recommendation for this security.
Find out moreWhat is the Krebs Biochemicals And Industries dividend yield?
Krebs Biochemicals And Industries does not currently pay a dividend.
Does Krebs Biochemicals And Industries pay a dividend?
Krebs Biochemicals And Industries does not currently pay a dividend.
When does Krebs Biochemicals And Industries next pay dividends?
Krebs Biochemicals And Industries does not currently pay a dividend.
How do I buy Krebs Biochemicals And Industries shares?
To buy shares in Krebs Biochemicals And Industries you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Krebs Biochemicals And Industries?
As of the previous close price of IN₹78.41, shares in Krebs Biochemicals And Industries had a market capitalisation of IN₹1.70bn.
Where are Krebs Biochemicals And Industries shares listed?
Here are the trading details for Krebs Biochemicals And Industries:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: KREBSBIO
What kind of share is Krebs Biochemicals And Industries?
Based on an overall assessment of its quality, value and momentum Krebs Biochemicals And Industries is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Krebs Biochemicals And Industries share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Krebs Biochemicals And Industries share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Krebs Biochemicals And Industries. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +3.85%.
As of the last closing price of IN₹78.41, shares in Krebs Biochemicals And Industries were trading -10.78% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Krebs Biochemicals And Industries PE Ratio?
The Krebs Biochemicals And Industries PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹78.41.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Krebs Biochemicals And Industries?
Krebs Biochemicals And Industries' management team is headed by:
- R. Ravi - NEC
- Pabitra Bhattacharya - MDR
- Taruni Banda - SEC
- Avinash Ravi - NED
- Jitendra Shah - NED
- Satish Khivsara - IND
- Raj Verma - IND
- G. Prasad - NID
- R. Satyanarayana - NID